News | 22 May 2012
Some drugmakers assert they are unable to create cheaper generic versions of drugs because their rivals are exploiting a legal loophole. It all comes down to process: To get a generic drug approved for sale, a company has to test a sample of the ...
Click on the link to read the full article at Washington Post
(This link will open in a new window)